Navigation Links
Access Highlighted in Recent BusinessWeek Article
Date:9/11/2007

DALLAS, Sept. 11 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that renowned business columnist Gene Marcial of BusinessWeek, highlighted Access Pharmaceuticals in the most recent edition dated September 17, 2007. The article is also available on http://www.BusinessWeek.com under the 'Inside Wall Street' column.

The article focused upon the major opportunity Access' lead compound, ProLindac, has to offer shareholders. ProLindac, a platinum-based drug that is currently in Phase II clinical trials for ovarian and colorectal cancer, has the potential to be a next generation cancer therapy, which is currently dominated by Eloxatin, a current platinum drug that produces revenues in excess of $2 billion and is close to patent expiration in the U.S. Marcial also noted that Dr. Esteban Cvitkovic, Access' Vice-Chairman (Europe) and Senior Director, Oncology Clinical R&D, was responsible for developing Eloxatin during his tenure at Sanofi-Aventis. The article references certain products of Somanta Pharmaceuticals in the cancer area. While Access has executed a definitive merger agreement with Somanta, the acquisition has not yet closed and the closing is still subject to the satisfaction of the closing conditions set forth in the merger Agreement. The consummation of the acquisition is subject to numerous closing conditions.

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase II clinical testing of patients with ovarian cancer and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery. Access has announced the
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Research explains why women lack equal access to angel capital
2. Abbott vs. Thailand has implications for innovation and access
3. More access points for Madison wireless
4. GE partner allows real-time access to patient data
5. Broadband access needs a champion, FCC commissioner says
6. UW Trace center makes sending packages accessible to all
7. Green Bay area businesses ramp up wireless access
8. GE Healthcare, MobileAccess to collaborate on hospital wireless
9. Stem-cell debate, wireless access and other endeavors heat up
10. Computer access brings more Wisconsinites to libraries
11. Promega to get early access to WARF technologies under new agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...nhua-- Huifeng,Bio-Pharmace..., a leading,developer and producer of plant extrac...rmaceutical, nutraceutical and food production in ...n will be made available via,Standard & Poor,s Mar...rvice that enables subscribing publicly traded com...
(Date:7/3/2008)...- AMDL, Inc. (Amex:,ADL), a...rtered in Tustin,Ca., with operations in Shenzhen...s released its investor presentation which is avai...p://www.amdl.com ., About AMDL:, AMDL, Inc. is a...any is,headquartered in Tustin, California with op...
(Date:7/2/2008)...pany to offer choice of two distinct drugs on ... NATICK, Mass., July 2 /- ...announced that the U.S. Food and Drug,Administrati...uting,Coronary Stent System for the treatment of c...ate-labeled XIENCE(TM) V Everolimus-Eluting Corona...
(Date:7/2/2008)... /- Biopure Corporation,(Na...n agreement with,purchasers for a private placemen...million in tranches, assuming no exercise of the w...ds for working capital and general,corporate purpo...and,subsequent closings are subject to conditions ...
Breaking Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2AMDL Announces Investor Relations Presentation Available on Website 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 2Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 3Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System 4Biopure Announces Private Equity Financing 2Biopure Announces Private Equity Financing 3
...sy. If you,re the new exec, people practically exp...list, or in some "key business process." If you,re... wait too long before there,s an upgrade, a new pr...ge beast is off rummaging through the underbrush o...egins with the focus groups and Post-It-note exerc...
...d at the performance of Midwest publicly traded bi...he overall performance of the major U.S. stock ind...lar really measure the biotech sector in different...ut 20 biotech stocks (most of which are the large-...formers). No Midwest biotech companies are listed ...
...f General Electric has just been ranked the number...the 11th Annual Healthcare Informatics 100 publish...tics , where companies are ranked by their health ...re Informatics asks over the 1,700 companies regis...e IT earnings for the previous year. The data is c...
...r two years, the Wisconsin Life Sciences and Vent...al Device Conference have decided to go their sep...nd themes, these autumn conferences are now being ... partner at Venture Investors LCC and member of ...iginally combined to set Wisconsins event apart fr...
Other Biology Technology:Domesticating the change beast 2Domesticating the change beast 3VC Community Shares Perspectives on Midwest Life Science Funding 2VC Community Shares Perspectives on Midwest Life Science Funding 3VC Community Shares Perspectives on Midwest Life Science Funding 4Wisconsin giant continues to dominate the health care IT market 2Life science VC and biotech confabs to fly solo this fall 2
(Date:7/2/2008)...a, July 2, 2008 Volunteers representing the Juven...RF), the American Diabetes Association (ADA) and t...t Senator Byron Dorgan with the 2008 Congressional...the Special Diabetes Program (SDP) in Congress. T...i Room at the Hilton Garden Inn in Grand Forks. ...
(Date:7/2/2008)...ble in Spanish . , Most of the functions perfo...een proteins, which recognise their binding partne...rface. There are many kinds of interactions; howev...tive of structural biology are those which are tra...rs through a large section of the protein surface-...
(Date:7/2/2008)...rcial flower and plant growers know all too well t...wering the value and deterring healthy growth of p...mmercial nursery owners resort to the expensive pr...Some growers use herbicides, but efficacy of herbi...pecies produced in nurseries, and many herbicides ...
(Date:7/1/2008)... from Kettering Police Department Streamlines ...LL, N.J., July 1 /PRNewswire-FirstCall/ -- BIO-key... leader in finger-based biometric,identification a... from the,Kettering, Ohio Police Department for Mo...ed services. With this award, officers on patrol w...
Breaking Biology News(10 mins):Sen. Byron Dorgan to be honored 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Ethanol byproduct produces green results 2Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software 2Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software 3Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference 427 1Theater Classes Help Docs Bedside Manners 744 1Theater Classes Help Docs Bedside Manners 744 2Theater Classes Help Docs Bedside Manners 744 3AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium 426 1AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium 426 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 1Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 424 3
...vey of U.S. adults has found that a majority belie...ling the global AIDS epidemic and are confident su...urveyed felt it personally important to help suppo...ctance to support a friend or family member’s part...e were among the conflicting findings of a telepho...
...salamanders at a Georgia military base are the gui...hers whose goal is to develop methods to better de...ot finding any flatwoods salamanders since 2001, F...re looking for a better survey method, said Mark B...,s Environmental Sciences Division. A Strategic En...
...rchers at the University of Minnesota have identif...t the development and function of blood stem cells...r to harnessing the power of stem cells for diseas... and differentiate to generate approximately 200 b...s. To maintain their numbers over time, blood stem...
...e of the largest adult vaccine clinical trials eve...cine against shingles (zoster vaccine) prevented a...d skin infection--and dramatically reduced its sev...got the disease. The findings appear in the June 2...he Shingles Prevention Study, conducted over 5 ½-y...
Other Biology News:Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research 2Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research 3Elusive salamanders have role in developing new sampling models 2Elusive salamanders have role in developing new sampling models 3Fish and chips: A fast track to understanding blood development 2Experimental shingles vaccine proves effective in nationwide study 2Experimental shingles vaccine proves effective in nationwide study 3Experimental shingles vaccine proves effective in nationwide study 4
Golgi Sampler Kit 10g each
AMAP Multi Site-directed Mutagenesis Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: dry ice
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells
Biology Products: